Bryan Joseph Gros, PHD - Medicare Psychologist in Baton Rouge, LA

Bryan Joseph Gros, PHD is a medicare enrolled "Psychologist - Counseling" provider in Baton Rouge, Louisiana. His current practice location is 4615 Government St Bldg 2, Baton Rouge, Louisiana. You can reach out to his office (for appointments etc.) via phone at (225) 922-2656.

Bryan Joseph Gros is licensed to practice in Louisiana (license number 748) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1649330796.

Contact Information

Bryan Joseph Gros, PHD
4615 Government St Bldg 2,
Baton Rouge, LA 70806-5820
(225) 922-2656
(225) 922-0068



Healthcare Provider's Profile

Full NameBryan Joseph Gros
GenderMale
SpecialityPsychologist - Counseling
Location4615 Government St Bldg 2, Baton Rouge, Louisiana
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1649330796
  • Provider Enumeration Date: 12/11/2006
  • Last Update Date: 08/31/2009
  Medicare PECOS Information:
  • PECOS PAC ID: 1254796741
  • Enrollment ID: I20230505002478

Medical Identifiers

Medical identifiers for Bryan Joseph Gros such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1649330796NPI-NPPES
1542733MedicaidLA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103TC1900XPsychologist - Counseling 748 (Louisiana)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Bryan Joseph Gros allows following entities to bill medicare on his behalf.
Entity NameCapital Area Human Services District
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1174681852
PECOS PAC ID: 2769450733
Enrollment ID: O20081118000007

News Archive

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.

Scientists establish a goal of creating vaccine gene chip to speed up vaccine testing

Testing the efficacy of vaccines in clinical trials takes years, even decades. Yet challenging infections like HIV, malaria and dengue are striking today. To speed up vaccine testing, scientists at the Emory Vaccine Center have established a goal of creating a "vaccine gene chip."

New approach to identify potentially health relevant chemical combinations

About 350,000 chemicals are registered worldwide. Some of these can contribute to human exposure to substances and mixtures via products, applications or food. In order to protect people in everyday life and at work from potentially dangerous chemicals, the legislature has established a comprehensive legal framework. Notably the corresponding acts and regulations mainly cover the evaluation of individual substances and defined mixtures within their respective regulatory silos.

World's largest medical robotic conference

The International Robotic Urology Symposium 2011 is hosted by the Henry Ford Vattikuti Urology Institute and the Vattikuti Foundation.

Read more Medical News

› Verified 1 days ago

Entity NameCapital Area Human Services District
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1710047980
PECOS PAC ID: 2769450733
Enrollment ID: O20081118000023

News Archive

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.

Scientists establish a goal of creating vaccine gene chip to speed up vaccine testing

Testing the efficacy of vaccines in clinical trials takes years, even decades. Yet challenging infections like HIV, malaria and dengue are striking today. To speed up vaccine testing, scientists at the Emory Vaccine Center have established a goal of creating a "vaccine gene chip."

New approach to identify potentially health relevant chemical combinations

About 350,000 chemicals are registered worldwide. Some of these can contribute to human exposure to substances and mixtures via products, applications or food. In order to protect people in everyday life and at work from potentially dangerous chemicals, the legislature has established a comprehensive legal framework. Notably the corresponding acts and regulations mainly cover the evaluation of individual substances and defined mixtures within their respective regulatory silos.

World's largest medical robotic conference

The International Robotic Urology Symposium 2011 is hosted by the Henry Ford Vattikuti Urology Institute and the Vattikuti Foundation.

Read more Medical News

› Verified 1 days ago

Entity NameCapital Area Human Services District
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1730104654
PECOS PAC ID: 2769450733
Enrollment ID: O20100114000532

News Archive

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.

Scientists establish a goal of creating vaccine gene chip to speed up vaccine testing

Testing the efficacy of vaccines in clinical trials takes years, even decades. Yet challenging infections like HIV, malaria and dengue are striking today. To speed up vaccine testing, scientists at the Emory Vaccine Center have established a goal of creating a "vaccine gene chip."

New approach to identify potentially health relevant chemical combinations

About 350,000 chemicals are registered worldwide. Some of these can contribute to human exposure to substances and mixtures via products, applications or food. In order to protect people in everyday life and at work from potentially dangerous chemicals, the legislature has established a comprehensive legal framework. Notably the corresponding acts and regulations mainly cover the evaluation of individual substances and defined mixtures within their respective regulatory silos.

World's largest medical robotic conference

The International Robotic Urology Symposium 2011 is hosted by the Henry Ford Vattikuti Urology Institute and the Vattikuti Foundation.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bryan Joseph Gros is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Bryan Joseph Gros, PHD
4615 Government St Bldg 2,
Baton Rouge, LA 70806-5820

Ph: (225) 922-0474
Bryan Joseph Gros, PHD
4615 Government St Bldg 2,
Baton Rouge, LA 70806-5820

Ph: (225) 922-2656

News Archive

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.

Scientists establish a goal of creating vaccine gene chip to speed up vaccine testing

Testing the efficacy of vaccines in clinical trials takes years, even decades. Yet challenging infections like HIV, malaria and dengue are striking today. To speed up vaccine testing, scientists at the Emory Vaccine Center have established a goal of creating a "vaccine gene chip."

New approach to identify potentially health relevant chemical combinations

About 350,000 chemicals are registered worldwide. Some of these can contribute to human exposure to substances and mixtures via products, applications or food. In order to protect people in everyday life and at work from potentially dangerous chemicals, the legislature has established a comprehensive legal framework. Notably the corresponding acts and regulations mainly cover the evaluation of individual substances and defined mixtures within their respective regulatory silos.

World's largest medical robotic conference

The International Robotic Urology Symposium 2011 is hosted by the Henry Ford Vattikuti Urology Institute and the Vattikuti Foundation.

Read more News

› Verified 1 days ago


Psychologist in Baton Rouge, LA

Dr. Franziska Noacklesage, PH.D.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 7784 Innovation Park Dr, Baton Rouge, LA 70820
Phone: 225-343-4232    Fax: 225-343-4233
Dr. Raymond Tucker, PHD
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808
Phone: 225-765-6565    
Paula J Varnado-sullivan, PH.D
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 740 Colonial Dr, Baton Rouge, LA 70806
Phone: 225-216-9422    Fax: 225-216-1260
Mary Lou Kelley, PH.D.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 7936 Wrenwood Blvd Ste B, Baton Rouge, LA 70809
Phone: 225-925-2036    
Dr. Adam Robert Reinwald, PSY.D.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 7850 Anselmo Ln, Baton Rouge, LA 70810
Phone: 985-276-8863    
Dr. Rachel Renee Stokes, PSY.D.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 2333 Government St, Baton Rouge, LA 70806
Phone: 225-383-3414    
Dr. Alyson Powell Mccain, PHD.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 10211 Siegen Lane, Ste 2b, Baton Rouge, LA 70810
Phone: 225-767-3121    Fax: 225-767-3122

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.